SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 81.00 |
| Enterprise Value ($M) | 178.51 |
| Book Value ($M) | -214.69 |
| Book Value / Share | -1.63 |
| Price / Book | -0.38 |
| NCAV ($M) | -268.82 |
| NCAV / Share | -2.04 |
| Price / NCAV | -0.30 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.48 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.19 |
| Current Ratio | 0.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 50.42 |
| Assets | 104.54 |
| Liabilities | 319.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | SCLX Stock Acquisition JV LLC | 33.30 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 142,014 | 625,135 | 22.72 | |
| 185,658 | 621,970 | 29.85 | |
| 287,345 | 1,359,636 | 21.13 | |
| 659,891 | 2,918,665 | 22.61 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SABS – SAB Biotherapeutics, Inc. | SAVA – Cassava Sciences, Inc. |
| SBFM – Sunshine Biopharma, Inc. | SGMO – Sangamo Therapeutics, Inc. |
| SHPH – Shuttle Pharmaceuticals Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io